Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com
'Make America Healthy Again' Platform to Be a Top Priority of RFK Jr. at HHS
Express News | U.S. CDC Report: Evidence Found Of Recent Bird Flu Infections Among 3 Cattle Veterinarians
Market Chatter: RFK Jr. Confirmed as HHS Head by Senate
ViiV Healthcare And The Pan-Canadian Pharmaceutical Alliance Finalize Negotiations For APRETUDE For HIV-1 Pre-Exposure Prophylaxis
TD Cowen Maintains GlaxoSmithKline(GSK.US) With Hold Rating, Maintains Target Price $45
GSK's Speciality Medicines Arm Gets the Seal of Approval From UK Broker | LSE:GSK, NYSE:GSK
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
GlaxoSmithKline (GSK.US) has submitted a new indication application for mepolizumab injection for the treatment of COPD in China.
According to GSK's official website and public information, it is speculated that the indication for the marketing application of mepolizumab in China may be chronic obstructive pulmonary disease (COPD).
Fund Update: PRIMECAP MANAGEMENT CO/CA/ Just Disclosed New Holdings
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch
Tariffs Expected to Bring Pharmaceutical Price Bumps, Shortages -- Market Talk
Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)
Bird Flu Reaches NYC as Live Poultry Markets Shut Down
AlphaValue/Baader Europe Confirms Positive Stance on GSK
Bear Of The Day: GSK PLC (GSK)
GSK Prelims Get City Thumbs up as Investment Banks Upgrade | LSE:GSK, NYSE:GSK
Hold Rating on GlaxoSmithKline: Balancing Promising Guidance With Existing Challenges
GSK PLC (GSK) Q4 2024 Earnings Call Highlights: Strong Specialty Medicines Drive Growth Amid ...
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)